{"version":"1.0","provider_name":"Open to Debate","provider_url":"https:\/\/opentodebate.org","title":"Is the FDA Too Cautious? - Open to Debate","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"CXXsvp7ZoP\"><a href=\"https:\/\/opentodebate.org\/debate\/is-the-fda-too-cautious\/\">Is the FDA Too Cautious?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/opentodebate.org\/debate\/is-the-fda-too-cautious\/embed\/#?secret=CXXsvp7ZoP\" width=\"600\" height=\"338\" title=\"&#8220;Is the FDA Too Cautious?&#8221; &#8212; Open to Debate\" data-secret=\"CXXsvp7ZoP\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/opentodebate.org\/wp-content\/uploads\/2023\/06\/FDA_NoTitle-1024x576.jpg","thumbnail_width":1024,"thumbnail_height":576,"description":"During the COVID-19 pandemic, the Atlantic criticized the US Food and Drug Administration for moving too slowly to approve vaccines with the provocative headline \u201cThe Death Toll of Delay.\u201d Not long before, National Public Radio ran a piece titled \u201cOne-Third of New Drugs Had Safety Problems After FDA Approval.\u201d As the agency tries to move [&hellip;]"}